Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 5,637,920 | 4,848,170 | 4,044,840 | 3,540,000 | 2,824,000 |
| Cost of Goods | 1,532,550 | 1,344,350 | 1,133,700 | 932,000 | 710,000 |
| Gross Profit | 4,105,360 | 3,503,820 | 2,911,140 | 2,608,000 | 2,114,000 |
| Operating Expenses | 2,822,510 | 2,434,530 | 1,938,920 | 1,907,000 | 1,551,000 |
| Operating Income | 1,283,410 | 1,069,640 | 972,920 | 701,000 | 563,000 |
| Interest Expense | 0 | 0 | 34,590 | 0 | 15,000 |
| Other Income | 91,660 | 175,670 | 186,830 | 185,000 | 168,000 |
| Pre-tax Income | 1,375,070 | 1,245,310 | 1,125,160 | 886,000 | 716,000 |
| Income Tax | 395,790 | 408,140 | 384,810 | 310,000 | 257,000 |
| Net Income Continuous | 978,000 | 838,675 | 816,000 | 576,000 | 459,000 |
| Net Income | $979,280 | $837,170 | $740,350 | $576,000 | $459,000 |
| EPS Basic Total Ops | 0.15 | 0.12 | 0.12 | 0.09 | 0.07 |
| EPS Basic Continuous Ops | 0.15 | 0.12 | 0.12 | 0.09 | 0.07 |
| EPS Diluted Total Ops | 0.15 | 0.12 | 0.12 | N/A | N/A |
| EPS Diluted Continuous Ops | 0.15 | 0.12 | 0.12 | N/A | N/A |
| EBITDA(a) | $1,605,720 | $1,385,600 | $1,219,650 | $888,000 | $691,000 |